Skip to content
Joints & Immunity — JAK inhibitors

Tofacitinib

Prescription only

Tablet that blocks inflammation signals for arthritis and colitis.

Starts working
Varies
Half-life
About 3 hours
In use since
2012
Pregnancy
Usually avoided

Overview

Tofacitinib is an oral JAK inhibitor for rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. A 2021 safety study found higher risks of heart events, cancer and clots than with TNF inhibitors in older people with risk factors, so its use is now more restricted.

How it works

Blocks the relay inside immune cells that passes on inflammation signals.

Tofacitinib belongs to the JAK inhibitors. How JAK inhibitors work: block JAK enzymes that pass messages from several inflammation signals into immune cells.

Uses

  • Rheumatoid arthritis
  • Psoriatic arthritis
  • Ulcerative colitis
  • Ankylosing spondylitis

Available as: tablet, modified-release tablet, oral solution.

Typical dose

Adults
5 mg twice a day (10 mg twice a day for induction in ulcerative colitis).

Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.

Side effects

Common

Often mild and may settle with time

  • Cold-like infections
  • Headache
  • Diarrhoea
  • Raised cholesterol

Serious — get medical help

Uncommon, but need prompt attention

  • Shingles
  • Blood clots
  • Heart attacks and cancer in at-risk groups
  • Serious infections

Warnings

  • Avoided over 65, in smokers and with heart or clot risk unless no alternative
  • Shingles vaccination advised

Interactions

  • Strong CYP3A4 inhibitors — halve dose
  • Rifampicin — ineffective

Other medicines in the atlas that need care with Tofacitinib, grouped by the reason:

Reduced effectModerateWith Carbamazepine, Efavirenz, Enzalutamide, Griseofulvin, Modafinil and 5 more

Enzyme induction lowers levels of this medicine, which may stop it working.

What's usually done: Monitor effect; dose changes or alternatives may be needed. The effect lasts weeks after stopping the inducer.

Raised drug levelsModerateWith Clarithromycin, Darunavir, Erythromycin, Itraconazole, Lopinavir-ritonavir and 2 more

Blocking CYP3A4 increases levels of this medicine, so side effects become more likely.

What's usually done: A dose reduction, alternative or extra monitoring may be needed.

Check Tofacitinib against your own medicines

Pregnancy and breastfeeding

Usually avoided

Not recommended.

Breastfeeding advice can differ from pregnancy advice — check with a pharmacist, or the LactMed database.

Brand names

United States
Xeljanz
United Kingdom
Xeljanz
India
Tofacinix, Xeljanz
Australia
Xeljanz

Examples only; many generic versions exist. The same brand name can mean different products in different countries.

History

  1. 2021

    ORAL Surveillance trial leads to boxed warnings across JAK inhibitors.

Common questions

Is a tablet better than an injection?

It's more convenient, but the safety profile means it's chosen carefully.

Do I need a prescription for Tofacitinib?

Yes — Tofacitinib is prescription-only in most countries.

Can I take Tofacitinib during pregnancy?

Usually avoided. Not recommended. Always check with a doctor or midwife.

Sources and official information

Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.